Article
A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC
2022-09-06
Abstract excerpt
<title>Abstract</title> <p>The epidermal growth factor receptor (EGFR) is a tyrosine kinase receptor (TKR) frequently mutated in lung cancer. Despite initially favorable clinical responses of non-small cell lung cancer (NSCLC) patients harboring an EGFR mutation to treatment with tyrosine kinase inhibitors (TKIs), rapid resistance occurs mainly because of genetic alterations, including amplification of the hepato...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 23c0bba1-b151-5882-85e6-8aecfd1f3097
- DOI
- 10.21203/rs.3.rs-1957094/v1
